At a glance
- Originator Innothera
- Class Cardiotonics; Small molecules; Vascular disorder therapies
- Mechanism of Action Dinoprostone receptor antagonists; Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Venous insufficiency